Now Offering Monoclonal Antibody COVID-19 Treatment

You may be eligible to receive monoclonal antibody treatment at Bergen New Bridge if you currently have mild to moderate COVID-19 symptoms and are not hospitalized.

This treatment involves a single infusion of antibodies, which are laboratory-made proteins mimicking the immune system’s ability to fight off viruses. Monoclonal antibody treatment is available to those who meet certain high-risk medical requirements. Eligible patients must be treated within ten days of the initial onset of symptoms.

For more information or to be scheduled for a treatment evaluation, call 201.225.7130.


Or donate when you shop at Amazon with the Amazon Smile Program!